93 results
8-K
ORKA
Oruka Therapeutics Inc.
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
the chair of the Compensation Committee.
Nominating and Corporate Governance Committee
On August 29, 2024, Kristine Ball, Samarth Kulkarni and Peter … Harwin were appointed to the Nominating and Corporate Governance Committee of the Board (the “Nominating Committee”), and Peter Harwin was appointed
8-K
EX-3.6
ORKA
Oruka Therapeutics Inc.
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
, will comply with all of the Corporation’s corporate governance policies and guidelines related to conflict of interest, confidentiality, stock ownership … standard that may be applicable to the Corporation, and the Corporation’s corporate governance policies and guidelines) and the background of any
424B3
ORKA
Oruka Therapeutics Inc.
1 Aug 24
Prospectus supplement
4:10pm
governance and strategic changes at our company. In the event of stockholder activism, particularly with respect to matters which our board of directors
425
7iphp5 8ee0e05ed2ff
3 Apr 24
Business combination disclosure
7:33am
8-K
EX-2.1
agvodm0w7dwlfoii716i
3 Apr 24
ARCA biopharma and Oruka Therapeutics Announce Merger Agreement
7:31am
8-K
ttd6nza48y
6 Feb 24
Departure of Directors or Certain Officers
4:15pm